Healthcare Revenue: $371 million, up 10% on a constant currency basis. Consumable and Service Revenue Growth: 8% increase. Capital Equipment and Other Revenue Growth: 32% increase. Gross Margin: 63.1%, improved 80 basis points year over year. Operating Margin: 28.8%, improved 750 basis points year over year. Non-GAAP EPS: $1.36, representing 56% growth versus the prior year. GAAP Net Income from Continuing Operations: $47 million or $0.86 per share. Net Loss from Discontinued Operations: $218 million or $4.04 per share, including a $295 million impairment charge. Consolidated Net Loss: $171 million or $3.17 per share. Fiscal 2025 Revenue Guidance: $1.5 billion to $1.530 billion, reflecting 8% to 11% constant currency growth. Updated Operating Margin Guidance (Excluding Tariffs): 28% to 28.5%. Updated EPS Guidance (Excluding Tariffs): $5.30 to $5.60. Tariff Impact on Operating Margin: 210 to 250 basis points. Tariff Impact on EPS: $0.45 to $0.50. Warning! GuruFocus has detected 6 Warning Signs with MASI. Release Date: May 06, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Masimo Corp (NASDAQ:MASI) reported double-digit revenue growth and EPS growth of more than 50% for the first quarter. The healthcare revenue reached $371 million, growing 10% on a constant currency basis. Operating margin expanded by 750 basis points year over year, demonstrating strong operational efficiency. The company announced the divestiture of its Consumer Audio business, Sound United, to refocus on its core healthcare operations. Masimo Corp (NASDAQ:MASI) plans to leverage its leadership in pulse oximetry and expand into advanced monitoring categories, including capnography and hemodynamics. Negative Points The company faces potential impacts from new tariffs, which could affect operating margins and EPS. There was a reported net loss from discontinued operations of $218 million, including a $295 million impairment charge for the audio business. The timing of shipments related to a large tender contract resulted in lower-than-expected consumable sales for the quarter. Masimo Corp (NASDAQ:MASI) experienced an incident affecting its website and systems, though it is not expected to impact guidance. The company is navigating a fluid situation with tariffs, which could lead to increased costs and require mitigation strategies. Q & A Highlights Q: Can you provide more details on the impact of the large tender contract on Q1 results and its implications for future quarters? A: Micah Young, CFO, explained that the large tender contract resulted in higher-than-expected capital sales and lower-than-expected consumable sales due to timing. The rest of the business performed well, with double-digit growth in consumables and high single-digit growth in capital and other revenues. The timing issue is expected to normalize over the year, aligning with full-year expectations. Story Continues Q: How should we approach modeling the impact of tariffs for 2026, given the current uncertainty? A: Micah Young, CFO, advised against annualizing the tariff impact for 2026 due to the fluid environment and ongoing mitigation plans. The company is hopeful that actions taken will position them well by the end of 2025, but trade negotiations and other factors could change the situation. Q: Will the tariffs impact Masimo's long-term operating margin goals? A: Micah Young, CFO, expressed confidence in the underlying business performance, noting significant margin expansion in Q1. While tariffs present a challenge, the company is enacting mitigation plans and remains optimistic about achieving long-term margin goals. Q: Can you provide more details on the decision to sell Sound United and the use of proceeds? A: Micah Young, CFO, stated that the sale of Sound United was a competitive process, achieving fair market value. The proceeds will prioritize share repurchases, with the transaction expected to close by year-end, subject to regulatory clearances. Q: What are the near-term and long-term mitigation options for tariffs, especially concerning China? A: Micah Young, CFO, mentioned altering product sourcing, manufacturing, and supply chain as near-term actions. The company is also evaluating pricing opportunities and leveraging vertical integration. For China, shifting raw material sourcing is a longer-term strategy, with more updates expected as plans progress. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. View Comments
Masimo Corp (MASI) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Tariff Challenges
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...